Trial - Eczema (Atopic Dermatitis

Study ID: Johnson&Johnson Eczema (Atopic Dermatitis)

Summary

Study Details

Study Name	Age Requirements	Length of Study	Type of Treatment
Johnson&Johnson	18 +	81 Weeks (15 visits to the clinic)	Injection

Eczema (Atopic Dermatitis) Clinical Study

Who Can Participate?

Adults aged 18+ with moderate to severe eczema (atopic dermatitis) may be eligible to participate.

Inclusion Criteria

Chronic eczema with symptoms for at least 1 year
Eczema affecting an area equal to 10 hand prints or more
Tried eczema treatments in the last 6 months (topical) or 12 months (systemic) that were not effective or couldn’t continue using

Participant Information

No cost to participate or receive study treatment
Regular visits with study doctors who specialise in treating eczema (15 visits)
Will receive either an investigative subcutaneous injection treatment (study drug) or a placebo
Reimbursement for study-related expenses may be provided

How Long Will The Study Last?

Participation will last about 81 weeks and involve about 15 visits to the study research site.

Note: The investigational treatment has not been approved by Health Canada for eczema

Contact us about joining the trial

To be eligible for this trial, applicants MUST have a skin condition. We DO NOT accept volunteers who do not have a skin disease.

Fill out this form to get in touch or call our clinical trial line at #(289)-763-8666. We will contact you in 1-2 business days regarding your application to participate in the trial.

First Name

Last Name

Phone Number

Email Address

Postal Code

Sex

Best Time to Reach You

Best Contact Method

Check this box to confirm you meet the study requirements, and consent to: recieving text notifications/emails about the trial, and (1) sharing your information with the study site, and (2) our Privacy Policy (see below). All provided information is confidential and will not be shared without your consent.

Privacy Policy for SimcoDerm Clinical Trials

Your privacy is important to us, and we take the protection of your personal health information (PHI) seriously. This policy explains how we collect, use, and protect your information.

We collect information directly from you, including your name, contact details, health information, and treatment history.

We use your information to determine eligibility for clinical trials, manage appointments, and communicate with you about your participation in clinical trials.

Data Protection:

Your information is stored securely and is only accessible by authorized personnel. We use data encryption, conduct security audits, and implement strict access controls to ensure the protection of your personal information.

You have the right to access, amend, or request the deletion of your health records. To exercise these rights, send a request to our clinical trial support team.